OptiNose (Germany) Performance
| 0OP Stock | EUR 0.38 0.01 2.70% |
OptiNose holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of 11.61, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OptiNose will likely underperform. Use OptiNose total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to analyze future returns on OptiNose.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OptiNose are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, OptiNose reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 144.2 M | |
| Total Cashflows From Investing Activities | -62 K | |
| Free Cash Flow | -77.1 M |
OptiNose |
OptiNose Relative Risk vs. Return Landscape
If you would invest 968.00 in OptiNose on October 6, 2024 and sell it today you would lose (930.00) from holding OptiNose or give up 96.07% of portfolio value over 90 days. OptiNose is currently producing 13.9484% returns and takes up 131.8998% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than OptiNose, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
OptiNose Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OptiNose's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OptiNose, and traders can use it to determine the average amount a OptiNose's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1058
| Best Portfolio | Best Equity | 0OP | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 131.9 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average OptiNose is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OptiNose by adding it to a well-diversified portfolio.
OptiNose Fundamentals Growth
OptiNose Stock prices reflect investors' perceptions of the future prospects and financial health of OptiNose, and OptiNose fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OptiNose Stock performance.
| Return On Equity | -10.5 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.97) % | |||
| Operating Margin | (0.76) % | |||
| Current Valuation | 257.48 M | |||
| Shares Outstanding | 111.38 M | |||
| Price To Book | 23.88 X | |||
| Price To Sales | 2.27 X | |||
| Revenue | 74.65 M | |||
| EBITDA | (65.68 M) | |||
| Cash And Equivalents | 93.92 M | |||
| Cash Per Share | 1.76 X | |||
| Total Debt | 126.42 M | |||
| Book Value Per Share | (0.88) X | |||
| Cash Flow From Operations | (76.94 M) | |||
| Earnings Per Share | (0.86) X | |||
| Total Asset | 166.07 M | |||
About OptiNose Performance
By analyzing OptiNose's fundamental ratios, stakeholders can gain valuable insights into OptiNose's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if OptiNose has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if OptiNose has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people.Things to note about OptiNose performance evaluation
Checking the ongoing alerts about OptiNose for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OptiNose help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OptiNose is not yet fully synchronised with the market data | |
| OptiNose is way too risky over 90 days horizon | |
| OptiNose has some characteristics of a very speculative penny stock | |
| OptiNose appears to be risky and price may revert if volatility continues | |
| OptiNose has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 74.65 M. Net Loss for the year was (82.3 M) with profit before overhead, payroll, taxes, and interest of 65.5 M. | |
| OptiNose has accumulated about 93.92 M in cash with (76.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 78.0% of the company shares are owned by institutions such as pension funds |
- Analyzing OptiNose's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OptiNose's stock is overvalued or undervalued compared to its peers.
- Examining OptiNose's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OptiNose's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OptiNose's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OptiNose's stock. These opinions can provide insight into OptiNose's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for OptiNose Stock analysis
When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |